Table 3.
Group (n/%) | Best response | DCR | ORR | χ2 | P | |||
---|---|---|---|---|---|---|---|---|
CR | PR | SD | PD | |||||
TIPS+TACE (n=42) | 4 (9.52%) | 12 (28.57%) | 17 (40.47%) | 9 (21.44%) | 33 (78.56%) | 16 (38.09%) | 7.895 | 0.041 |
Endoscopy+TACE (n=38) | 2 (5.26%) | 7 (18.42%) | 12 (31.58%) | 17 (44.74%) | 21 (55.26%) | 9 (23.68%) |
CR – complete response; PR – partial response; PD – progressive disease; SD – stable disease; DCR (CR+PR+SD) – disease control rate; ORR (CR+PR), objective response rate; TIPS – transjugular intrahepatic portosystemic shunt; TACE – transarterial chemoembolization.